Sana Biotechnology to present business update at BofA Healthcare Conference on May 12, 2026

Sana Biotechnology announced it will webcast its presentation at the BofA Securities 2026 Healthcare Conference on May 12, 2026. CEO Steve Harr will provide a business overview and company update, highlighting Sana's focus on engineered cell therapies. The webcast will be available on Sana's investor relations website, with a replay accessible for 30 days. This event offers insights into Sana's progress and future plans in cell-based medicine development.